Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Riverwater Micro Opportunities Strategy Nathan Fredrick, CFA | “We added Lifeway Foods (LWAY) in April, the dominant U.S. producer of kefir. Lifeway reported record quarterly sales of $63 million, up 37% and driven by volume rather than price, with gross margin expanding meaningfully on favorable milk costs, and a major plant expansion remains on track for completion by year end. Lifeway Foods is the largest producer and marketer of kefir in the United States. Kefir is a tart, tangy cultured milk rich in probiotics, protein, calcium, and vitamin D, with roots in Eastern Europe dating back generations. Lifeway was the first company to introduce kefir to U.S. consumers on a commercial scale and dominates the market. The kefir category today is benefitting from durable consumer trends including increased awareness of gut health, high protein diets, and a widespread shift to better-for-you food. The company distributes through more than 25,000 retail locations across 48 states, with strong relationships with many of the top mass retailers in the country. The primary overhang on the stock, a multi-year governance dispute and multiple bids from Danone, were recently resolved. Lifeway is currently undergoing an approximately $50 million expansion of its Waukesha, WI manufacturing facility which will roughly double the plant's capacity. Management's 2027 EBITDA guidance of $47–$50 million highlights a significant margin expansion opportunity as the Waukesha facility ramps up and sustained sales growth drives operating leverage. Lifeway has mid- to high-teens sales growth and an improving free cash flow trajectory, reaching breakeven in 2026 and inflecting to positive the following year.” | NEUTRAL | Q2 2026 Jul 17, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
